This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Southern First (SFST) Q4 Earnings Top Estimates
by Zacks Equity Research
Southern First (SFST) delivered earnings and revenue surprises of 30.77% and 4.76%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Trustmark (TRMK) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Get a deeper insight into the potential performance of Trustmark (TRMK) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Amerant Bancorp Inc. (AMTB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Amerant Bancorp Inc. (AMTB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Trustmark (TRMK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trustmark (TRMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trustmark (TRMK) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Trustmark (TRMK) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Trustmark (TRMK) Lags Q3 Earnings Estimates
by Zacks Equity Research
Trustmark (TRMK) delivered earnings and revenue surprises of -7.25% and 1.51%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Raymond James (RJF) in Q4 Earnings?
by Zacks Equity Research
Higher interest rates, decent loan demand and past buyouts are expected to have supported Raymond James' (RJF) fiscal Q4 earnings amid weakness in IB and trading businesses.
Invesco (IVZ) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Manageable expense level and decent AUM balance are likely to have aided Invesco's (IVZ) Q3 earnings amid subdued market performance.
Southern First (SFST) Beats Q3 Earnings Estimates
by Zacks Equity Research
Southern First (SFST) delivered earnings and revenue surprises of 54.55% and 4.71%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
First Bancorp (FBNC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
First Bancorp (FBNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trustmark (TRMK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Trustmark (TRMK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Trustmark (TRMK) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Down -10.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Trustmark (TRMK)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Trustmark (TRMK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AUM Growth to Aid BlackRock's (BLK) Top Line Amid Cost Woes
by Zacks Equity Research
A continued rise in expenses may hurt BlackRock's (BLK) bottom-line growth. However, efforts to restructure the active equity business will likely aid the top line.
5 Reasons to Add Popular (BPOP) Stock to Your Portfolio Now
by Zacks Equity Research
Popular (BPOP) stock looks like an attractive investment option now, supported by strong fundamentals and decent growth prospects.
Earnings Estimates Moving Higher for Trustmark (TRMK): Time to Buy?
by Zacks Equity Research
Trustmark (TRMK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Trustmark (TRMK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Trustmark (TRMK) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trustmark (TRMK) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Trustmark (TRMK) delivered earnings and revenue surprises of 23.33% and 6.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Trustmark (TRMK) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Trustmark (TRMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Trustmark (TRMK) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Trustmark (TRMK) stock based on the movements in the options market lately.
5 Reasons to Add National Bank (NBHC) to Your Portfolio Now
by Zacks Equity Research
Supported by strong fundamentals and good growth prospects, the National Bank (NBHC) stock seems to be a viable investment option now.
4 Reasons to Add First BanCorp. (FBP) to Your Portfolio Now
by Zacks Equity Research
Supported by strong fundamentals and good growth prospects, First BanCorp. (FBP) stock seems to be a viable investment option now.
Synchrony (SYF) Ties Up to Better Serve the Hearing Care Space
by Zacks Equity Research
Synchrony Financial (SYF) aims to extend financing options to customers of Miracle-Ear who are in need of quality hearing care.
5 Reasons Why Trustmark Corporation (TRMK) Stock Is a Must Buy
by Zacks Equity Research
A solid loan and deposit balance, higher rates and a focus on improving fee income are likely to continue to support Trustmark Corporation's (TRMK) financials going forward.
All You Need to Know About Trustmark (TRMK) Rating Upgrade to Strong Buy
by Zacks Equity Research
Trustmark (TRMK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).